MRKR Marker Therapeutics Inc
Company Analysis
Latest News
🟢 Marker Therapeutics is trading 7.5% up in pre-market amid broader strength; no company-specific catalyst identified
Marker Therapeutics is trading 7.50% up now at $1.29, with the move appearing more consistent with broader pre-market strength than a company-specific...
🔴 Marker Therapeutics is trading 5.5% down today amid broader risk-off trading
Marker Therapeutics is trading at $1.21, down -5.47%, amid a broader risk-off session. - The NASDAQ Composite is down 0.55%, with energy-driven inflation...
🟢 Marker Therapeutics is trading 14% up today with no clear catalyst identified
Marker Therapeutics is trading at $1.34, up +13.98%, with no clear company-specific announcement identified for September 8, 2026. - The official release page...
🟢 Marker Therapeutics is trading 5% up today with no clear company-specific catalyst identified
Marker Therapeutics is trading at $1.24, up 5.05%, with no clear company-specific announcement dated September 8, 2026 identified. - The company’s official...
🟢 Marker Therapeutics is trading 5% up today as XBI gains 2.75%
Marker Therapeutics is trading 5.18% up now at $1.31, primarily as stronger biotechnology sentiment lifts the XBI sector benchmark, up 2.75%. - No fresh...
🔴 Marker Therapeutics is trading 6% down today as risk-off sentiment pressures biotech shares
Marker Therapeutics is trading at $1.25 (-5.64%) amid broader market weakness and a 4.24% biotechnology-sector decline. - The decline is occurring during the...
🔴 Marker Therapeutics falls 5.5% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Marker Therapeutics is trading 5.26% up today in pre-market as XBI rises 2.06%
Marker Therapeutics is trading 5.26% up at $1.60 in pre-market, following stronger biotechnology-sector sentiment as XBI rises 2.06%. - Shares gained 1.33%...
🟢 Marker Therapeutics is trading 5% up in after-hours trading amid stronger biotechnology sentiment
Marker Therapeutics is trading 5.26% up now at $1.60, aligned with stronger biotechnology sentiment after XBI gained 2.06% and broader risk appetite...
🟢 Marker Therapeutics is trading 6% up today as XBI rises 2.06%
Marker Therapeutics is trading 6% up now at $1.59, appearing supported by stronger biotech sentiment as XBI rises 2.06%. - The stock extended gains after...
🟢 Marker Therapeutics is trading 10.03% up today amid continued speculative momentum
Marker Therapeutics is trading 10.03% up at $1.53, amid continued speculative momentum with no confirmed fresh catalyst identified. - It closed at $1.39 on...
🟢 Marker Therapeutics is trading 5.25% up today
Marker Therapeutics is trading 5.25% up at $1.46, with no new company-specific announcement identified to explain the August 24, 2026 move. - It closed 13.93%...
Marker Therapeutics Gets a $10 Bull Case on a $1.35 Stock — Can a Tiny Cancer Therapy Firm Close That 640% Gap?
Shares of Marker Therapeutics surged 10.7% to $1.35 on August 21 after H.C. Wainwright reiterated its Buy rating and $10 price target — implying roughly 640%...
🟢 Marker Therapeutics is trading 10.66% up today after H.C. Wainwright reaffirmed Buy and $10 target
Marker Therapeutics is trading 10.66% up at $1.35 after H.C. Wainwright reiterated its Buy rating and $10 price target on August 21, 2026, citing progress...
🟢 Marker Therapeutics is trading 6.1% up today after H.C. Wainwright reiterated its Buy rating
Marker Therapeutics is trading 6.1% up now at $1.29 after H.C. Wainwright reiterated its Buy rating and $10 price target on August 21, 2026. - The analyst...
🔴 Marker Therapeutics falls 5.4% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Marker Therapeutics is trading 14.35% up today after biotech-sector strength lifted risk appetite
Marker Therapeutics is trading 14.35% up at $1.33 after biotech-sector strength lifted risk appetite on August 19, 2026. • Trading at $1.33 (+14.35%) • XBI is...
Marker Therapeutics narrows loss to $5 million, issues going concern warning
Marker Therapeutics reported a narrowed net loss of $5.0 million for the six months ended June 30, 2026. This result marks an improvement from the $8.5 million...
🟢 Marker Therapeutics is trading 5% up in pre-market
Marker Therapeutics is trading at $1.17, up 5.41% in pre-market after closing at $1.11 on August 13, 2026; no clear company-specific announcement explaining...
🟢 Marker Therapeutics is trading 5% up today ahead of its expected August 13 earnings report
Marker Therapeutics is trading 5% up at $1.18, with investors looking ahead to the company’s expected August 13 earnings report and interim clinical update. -...